Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Q BioMed Inc. stock logo
QBIO
Q BioMed
$0.00
$0.00
$0.00
$0.03
$15K1.8248,328 shs151,300 shs
Scopus BioPharma Inc. stock logo
SCPS
Scopus BioPharma
$0.00
$0.00
$0.00
$0.01
$13K-0.272,286 shs25 shs
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
$0.00
$0.00
$0.05
$4K1.94N/AN/A
Wellness Center USA, Inc. stock logo
WCUI
Wellness Center USA
$0.00
$0.00
$0.00
$14K2.662,923 shsN/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Q BioMed Inc. stock logo
QBIO
Q BioMed
0.00%0.00%0.00%-50.00%-50.00%
Scopus BioPharma Inc. stock logo
SCPS
Scopus BioPharma
0.00%0.00%0.00%0.00%-81.25%
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
0.00%0.00%0.00%0.00%0.00%
Wellness Center USA, Inc. stock logo
WCUI
Wellness Center USA
0.00%0.00%0.00%-80.00%-77.78%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Q BioMed Inc. stock logo
QBIO
Q BioMed
N/AN/AN/AN/AN/AN/AN/AN/A
Scopus BioPharma Inc. stock logo
SCPS
Scopus BioPharma
N/AN/AN/AN/AN/AN/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/AN/AN/AN/AN/AN/AN/AN/A
Wellness Center USA, Inc. stock logo
WCUI
Wellness Center USA
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Q BioMed Inc. stock logo
QBIO
Q BioMed
0.00
N/AN/AN/A
Scopus BioPharma Inc. stock logo
SCPS
Scopus BioPharma
0.00
N/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
0.00
N/AN/AN/A
Wellness Center USA, Inc. stock logo
WCUI
Wellness Center USA
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Q BioMed Inc. stock logo
QBIO
Q BioMed
$280K0.05N/AN/AN/A
Scopus BioPharma Inc. stock logo
SCPS
Scopus BioPharma
N/AN/AN/AN/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/AN/AN/AN/AN/AN/A
Wellness Center USA, Inc. stock logo
WCUI
Wellness Center USA
$660K0.00N/AN/AN/ANaN
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Q BioMed Inc. stock logo
QBIO
Q BioMed
-$2.05MN/A0.00N/AN/AN/AN/AN/A
Scopus BioPharma Inc. stock logo
SCPS
Scopus BioPharma
-$11.61MN/A0.00N/AN/AN/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Wellness Center USA, Inc. stock logo
WCUI
Wellness Center USA
-$750KN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Q BioMed Inc. stock logo
QBIO
Q BioMed
N/AN/AN/AN/AN/A
Scopus BioPharma Inc. stock logo
SCPS
Scopus BioPharma
N/AN/AN/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/AN/AN/AN/AN/A
Wellness Center USA, Inc. stock logo
WCUI
Wellness Center USA
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Q BioMed Inc. stock logo
QBIO
Q BioMed
N/A
Scopus BioPharma Inc. stock logo
SCPS
Scopus BioPharma
N/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/A
Wellness Center USA, Inc. stock logo
WCUI
Wellness Center USA
0.01%

Insider Ownership

CompanyInsider Ownership
Q BioMed Inc. stock logo
QBIO
Q BioMed
28.20%
Scopus BioPharma Inc. stock logo
SCPS
Scopus BioPharma
5.10%
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
4.50%
Wellness Center USA, Inc. stock logo
WCUI
Wellness Center USA
15.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Q BioMed Inc. stock logo
QBIO
Q BioMed
3145.10 million104.18 millionNot Optionable
Scopus BioPharma Inc. stock logo
SCPS
Scopus BioPharma
942.08 million39.94 millionNot Optionable
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
635.55 millionN/ANot Optionable
Wellness Center USA, Inc. stock logo
WCUI
Wellness Center USA
8143.19 millionN/ANot Optionable

Recent News About These Companies

Wellness Center attendance up
MCCTC Plans New Health and Wellness Center
Chamber holds ribbon cutting for Women’s Wellness Center

Media Sentiment Over Time

Q BioMed stock logo

Q BioMed OTCMKTS:QBIO

$0.0001 0.00 (0.00%)
As of 04/24/2025 02:14 PM Eastern

Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride Sr-89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, that is used for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, a novel chemotherapeutic for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutic drugs to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.

Scopus BioPharma stock logo

Scopus BioPharma NASDAQ:SCPS

$0.0003 0.00 (0.00%)
As of 04/23/2025

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs. It offers Duet Platform, which consists of signal transducer and activator of transcription 3 (STAT3), a master immune checkpoint inhibitor and toll-like receptor 9 (TLR9), as well as includes CpG-STAT3ASO (DUET-02), CpG-STAT3siRNA (DUET-01), and CpG-STAT3decoy (DUET-03); and that develops a suite of bifunctional oligonucleotides that activate antigen-presenting cells (APCs) in the tumor microenvironment that alleviates tumor immunosuppression to jump-start T cell-mediated immune responses. The company is also developing DUET-01, as a monotherapy targeting B-cell non-Hodgkin lymphoma; DUET-02 that provides systemic delivery for treatment of solid tumors comprising prostate or kidney cancers; and DUET-03, which targets the actual STAT3 transcription factor protein. Scopus BioPharma Inc. has licensing agreements with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.

Sophiris Bio stock logo

Sophiris Bio OTCMKTS:SPHS

Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA.

Wellness Center USA stock logo

Wellness Center USA OTCMKTS:WCUI

Wellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona.